Summary
Effects of several cytokines on des-gamma-carboxy prothrombin (PIVKA II) synthesis in human hepatoma cells were investigated to know the process of PIVKA II production during a liver allograft rejection. Human recombinant interleukin-6 (IL-6) significantly stimulated the PIVKA II synthesis without any influence on the cell proliferation. The effect was almost completely neutralized by the specific anti-IL-6 antibody. Neither tumor necrosis factor (TNF), interleukin-1 (IL-1) nor interferon-gamma (IFN-gamma) had such a stimulative effect. IL-6 appears to stimulate PIVKA II production, and would be a candidate of factors that enhance the production of PIVKA II during a liver allograft rejection.
Similar content being viewed by others
Abbreviations
- PFVKA II:
-
des-gamma-carboxy prothrombin
- TNF:
-
tumor necrosis factor
- IL-1:
-
interleukin-1
- IL-6:
-
interleukin-6
- IFN-gamma:
-
interferon-gamma
- ELISA:
-
enzyme-linked immunosorbent assay
References
Olson RE. The function and metabolism of vitamin K. Ann Rev Nutr 1984;4:284–302.
Suttie JW. Vitamin K-dependent carboxylase. Ann Rev Biochem 1985;54:459–477.
Liebman HA, Furie BC, Tong MJ, et al. Des-gamma-carboxy (abnormal) prothrombin as a serum marker of primary hepatocellular carcinoma. N Engl J Med 1984;310:1427–1431.
Fujiyama S, Morishita T, Hashiguchi O, et al. Plasma abnormal prothrombin (des-gamma-carboxy prothrombin) as a marker of hepatocellular carcinoma. Cancer 1988;61:1621–1628.
Nakao A, Iwaki Y, Iwatsuki S, et al. Significance of PIVKA II determination in human liver transplantation. Acta Hepat Jap 1991;32(supple 1):248. (in Japanese)
Huh N, Utakoji T. Production of HBs-antigen by two new human hepatoma cell lines and its enhancement by dexamethasone. Jpn J Cancer Res 1981;72:178–179.
Ono M, Ohta H, Ohhira M, et al. Des the impairment of gammacarboxylation have any inhibitory effect on the extracelular excretion of des-gamma-carboxy prothrombin (PIVKA II)? Igaku no Ayumi 1990;152:123–124. (in Japanese)
Naraki T, Watanabe K, Shimozuru Y, et al. Development and evaluation of the EIA kit for the detection of PIVKA II using double antibody sandwich system: Monoclonal antibody to PIVKA II and polyclonal antibody to prothrombin. Clin Immunol 1986;18:479–492. (in Japanese)
Sugo T, Watanabe K, Naraki T, et al. Chemical modification of gamma-carboxyglutamic acid residues in prothrombin elicits a conformation similar to that of abnormal (des-gamma-carboxy) prothrombin. J Biochem 1990;108:382–387.
Motohara K, Kuroki Y, Kan H, et al. Detection of vitamin K deficiency by use of an enzyme-linked immunoadsorbent assay for circulating abnormal prothrombin. Pediatr Res 1985;19:354–357.
Ono M, Ohta H, Ohhira M, et al. Measurement of immunoreactive prothrombin, des-gamma-carboxy prothrombin, and vitamin K in human liver tissues: Overproduction of immunoreactive prothrombin in hepatocellular carcinoma. Am J Gastroenterol 1990; 85:1149–1154.
Van Damme J, Opdenakker G, Simpson RI, et al. Identification of the human 26-kD protein, interferon beta2 (IFN-beta2), as a B cell hybridoma/plasmacytoma growth factor induced by interleukin 1 and tumor necrosis factor. J Exp Med 1987;165:914–919.
Nordan RP, Pumphrey JG, Rudikoff S. Purification and NH2-terminal sequence of a plasmacytoma growth factor derived from the murine macrophage cell line P388D1. J Immunol 1987;139:813–817.
Tosato G, Seamon KB, Goldman ND, et al. Monocyte-derived human B-cell growth factor identified as interferon-beta2 (BSF-2, IL-6). Science 1988;239:502–504.
Kohda H, Uede T, Yuasa H, et al. Construction of rat-mouse T cell hybridomas that express regulatable rat interleukin 2 receptor. J Immunol 1986;137:1557–1563.
Ono M, Ohta H, Ohhira M, et al. Measurement of imunoreactive prothrombin precursor and vitamin K-dependent gammacarboxylation in human hepatocellular carcinoma tissues: Decreased carboxylation of prothrombin precursor as a cause of des-gamma-carboxy prothrombin synthesis. Tumor Biol 1990;11: 319–326.
Imagawa DK, Millis JM, Olthoff KM, et al. The role of tumor necrosis factor in allograft rejection. Transplantation 1990;50:219–225.
Maury CPJ, Teppo AM. Raised serum level of cachectin/tumor necrosis factor-alpha in renal allograft rejection. J Exp Med 1987;166:1132–1137.
Yoshimura N, Oka T, Kahan BD: Sequential determinations of serum interleukin-6 levels as an immunodiagnostic tool to differentiate rejection from nephrotoxicity in renal allograft recipients. Transplantation 1991;51:172–176.
Vandenbroecke C, Caillat-Zucman S, Legendre C, et al. Differential is situ expression of cytokines in renal allograft rejection. Transplantation 1991;51:602–609.
Ford HR, Hoffman RA, Tweardy DJ, et al. Evidence that production of interleukin-6 within the rejecting allograft coincides with cytotoxic T lymphocyte development. Transplantation 1991;51: 656–661.
Gauldie J, Richards C, Haarnish D, et al. Interferon beta2/B-cell stimulatory factor type 2 shares identify with monocyte-derived hepatocyte-stimulating factor and regulates the major acute phase protein response in liver cells. Proc Natl Acad Sci USA 1987; 84:7251–7255.
Ohhira M, Ono M, Kohda H, et al. Effects of dibutyryl cyclic AMP for secretion of PIVKA II from Hu-Hl cells. Jpn J Gastroenterol 1991;88:2728. (in Japanese)
Nanes MS, Rubin J, Titus L, et al. Tumor necrosis factor-alpha inhibits 1,25-dihydroxyvitamin D3-stimulated bone Gla protein synthesis in rat osteosarcoma cells (ROS 17/2.8) by a pretranslational mechanism. Endocrinology 1991;128:2577–2582.
Shiota G, Rhoads DB, Wang TC, et al. Hepatocyte growth factor inhibits growth of hepatocellular carcinoma cells. Proc Natl Acad Sci USA 1992;89:373–377.
Kohda H, Ono M, Sekiya C, et al. Detection of PIVKA II produced by human hepatoma cells in nude mice. Human Cell 1991;4:63–66.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ono, M., Kohda, H., Naraki, T. et al. The effect of IL-6 on the des-gamma-carboxy prothrombin synthesis in human hepatoma cells. Gastroenterol Jpn 27, 745–750 (1992). https://doi.org/10.1007/BF02806527
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02806527